SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (5420)2/11/1998 12:34:00 PM
From: Chris Delap  Read Replies (1) | Respond to of 23519
 
TA,
Do you mean that PFE is having trouble getting drugs to market or do they not have a lot of new drugs coming out?

Chris



To: Tunica Albuginea who wrote (5420)2/11/1998 5:14:00 PM
From: Bradpalm1  Read Replies (1) | Respond to of 23519
 
<<PFE has IMHO and that of pharmacists I talked to a VERY WEAK NEW DRUG pipeline.They are living on old glories.>>

This just proves that you don't know what you're talking about, Tuna. ANY pharmacist or KNOWLEDGABLE physician will tell you that not only does Pfizer have the strongest pipeline in the industry (52 drugs going through Phase I, II, and III trials), Viagra will be a 2-4 billion product and the cornerstone of ED management in the future. Expect the announcement of FDA approval within the next month.

Trashing Pfizer and spreading misinformation about Viagra will not help Vivus break out from this slump or enhance your shrinking credibility on this thread.

Bradpalm1